Mekiri Bio, Inc. — Form D
Mekiri Bio, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-10-16. The offering totals $2.0M, of which $1.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-10-16
- Form: D
- Accession: 0002088062-25-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $1.0M
- Remaining: $1.0M
- Investors: 1
- Date of first sale: 2025-08-25
- Revenue range: Not Applicable
- SEC file number: 021-561035
Issuer
- Name: Mekiri Bio, Inc.
- CIK: 0002088062
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: 68 HARRISON AVENUE, BOSTON, MA, 02111
- Phone: 617-203-8458
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Aaron DiAntonio | Director | Boston, MA |
| Corey McCann | Director | Boston, MA |
| Anita DiFazio | Executive Officer | Boston, MA |
| Debbie Lin | Executive Officer | Boston, MA |
More